| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,954 | 964 | 1,483 | 1,427 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 6,954 | 964 | 1,483 | 1,427 | | | Operating Expenses | | Research Development | 1,227 | 1,364 | 3,049 | 2,742 | | Selling General and Administrative | 2,576 | 1,928 | 2,483 | 1,666 | | Non Recurring | 1,187 |
-
|
-
|
-
| | Others |
-
|
-
|
-
| 625 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,963 | (2,328) | (4,049) | (3,606) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,900 | 103 | 75 | 180 | | Earnings Before Interest And Taxes | 3,863 | (2,226) | (3,973) | (3,485) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 3,863 | (2,226) | (3,973) | (3,485) | | Income Tax Expense |
-
|
-
|
-
| 46 | | Minority Interest |
-
|
-
|
-
| 0 | | | | Net Income From Continuing Ops | 3,863 | (2,226) | (3,973) | (3,531) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,863 | (2,226) | (3,973) | (3,531) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,863 | ($2,226) | ($3,973) | ($3,531) |
|
0.01% Nasdaq 
0.03 (2.56%) 
Income Statement
